Children and adolescents with type 1 diabetes in Aotearoa New Zealand : An online survey of workforce and outcomes 2021
Journal of Paediatrics and Child Health · 2024
DOI: 10.1111/jpc.16566 ↗At a glance
Journal article in Journal of Paediatrics and Child Health, 2024. Written by Calum Fisher and 7 co-authors. Institution: Department of Paediatrics, University of Otago, Dunedin, New Zealand. Major MEDLINE topics: Diabetes Mellitus, Type 1. Cited 3 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY 4.0).
Topics: Diabetes mellitus, Kinderkrankenpflege
Abstract (original language)
Aims
To survey the national workforce that manages children and adolescents with type 1 diabetes (T1D) in Aotearoa New Zealand and compare with glycaemic outcomes for 2021.
Methods
A representative from each tertiary and regional diabetes service in Aotearoa New Zealand was asked to participate in an online survey assessing health‐care professional (HCP) workforce numbers operating for the 2021 calendar year. Regional full‐time‐equivalent (FTE), glycaemic outcomes and population demographics were compared to a previously reported workforce surveys (2015 and 2019).
Results
Seventeen sites responded – including all four large tertiary centres – serving >99% of children and adolescents with T1D in Aotearoa New Zealand. HCP resourcing varied across sites, with median (range) HCP/100 patient ratios of: doctors: 0.40 (0.16–1.11), nurses: 1.19 (0.29–5.56), dietitians: 0.25 (0–1.11) and psychologist/social workers: 0 (0–0.26). No site met all of the International Society of Paediatric and Adolescent Diabetes (ISPAD) recommendations of HCP/100 patient ratios. Measures of socio‐economic deprivation predicted HbA1c, rather than the diabetes clinic attended. Overall, only 15.1% (240/1585) of patients had an HbA1c less than the recommended 53 mmol/mol.
Conclusions
The Aotearoa New Zealand workforce for children and adolescents with T1D is under‐resourced and no site meets the ISPAD recommendations. There has been no significant increase in HCP/100 patient ratios compared to previous workforce surveys over the last decade. Few children and adolescents with T1D meet the recommended HbA1c. Resourcing according to recommended clinical need is required if equity in outcomes for young people with T1D is to be addressed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Paediatrics, University of Otago, Dunedin, New Zealand.
- Biostatistics and Computation Biology Unit, University of Otago, Dunedin, New Zealand.
- Paediatric Department, Te Whatu Ora - Health New Zealand, Waitaha Canterbury, Christchurch, New Zealand.
- Endocrinology Department, Te Whatu Ora - Health New Zealand, Waitaha Canterbury, Christchurch, New Zealand.
- Paediatric Endocrinology Department, Te Whatu Ora - Health New Zealand, Waitaha Canterbury, Christchurch, New Zealand.
- Starship Child Health, Te Whatu Ora - Health New Zealand, Te Toka Tumai Auckland, Auckland, New Zealand.
ORCID profiles: Jonathan Williman, Benjamin J Wheeler
Cite
APA
Fisher, C., Williman, J., Burnside, M., Davies, H., Jefferies, C., Paul, R., Wheeler, B. J., & de Bock, M. (2024). Children and adolescents with type 1 diabetes in Aotearoa New Zealand : An online survey of workforce and outcomes 2021. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16566
Vancouver
Fisher C, Williman J, Burnside M, Davies H, Jefferies C, Paul R, et al. Children and adolescents with type 1 diabetes in Aotearoa New Zealand : An online survey of workforce and outcomes 2021. Journal of Paediatrics and Child Health. 2024. doi:10.1111/jpc.16566
BibTeX
@article{Fisher2024,
author = {Fisher, Calum and Williman, Jonathan and Burnside, Mercedes and Davies, Hannah and Jefferies, Craig and Paul, Ryan and Wheeler, Benjamin J and de Bock, Martin},
title = {Children and adolescents with type 1 diabetes in Aotearoa New Zealand : An online survey of workforce and outcomes 2021},
journal = {Journal of Paediatrics and Child Health},
year = {2024},
doi = {10.1111/jpc.16566}
}
EUVIMED